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Symposium: Promoting and Managing Genome Innovation
Suzanne A. Sprunger & Gianna Julian-Arnold, Introduction
. . . . . . . . . . . . . . . . . . . . . . . . . . 197
Elaine Alma Draper, Social Issues of Genome Innovation and
Intellectual Property
Dr. Draper's focus is the use of personal information derived from genome
research. She identifies several potential problems, including access to and control of
genetic information, employment discrimination and social stratification. She also
recommends possible solutions.
......................... 201
Kate H. Murashige, Genome Research and Traditional Intellectual
Property Protection - A Bad Fit?
Dr. Murashige addresses the need for a patent system more closely tailored to the
needs of biotechnology. For example, the obviousness requirement may interfere with
using patents to recoup high costs of work when it could arguably be done by
researchers of ordinary skill.
• . . . . . . . . . . . . . . . . . . . . . . . . . 231
Phillip K. Russell, Development of Vaccines to Meet Public Health
Needs: Incentives and Obstacles
Dr. Russell explains how such matters as high 'costs of regulation, lack of an
effective plan for delivery (particularly abroad) and politics can interfere with
providing globally needed vaccines.
. . . . . . . . . . . . . . . . . . . . . . . . . . 239
Brian C. Cunningham, Impact of the Human Genome Project at the
Interface between Patent and FDA Laws
Mr. Cunningham stresses the broad scope of biotechnological innovations.
Besides endorsing the need for a new oversight commission to deal with potential
social issues, he suggests, for example, that some products should be treated like
biologics rather than new drugs.
Jeffrey N. Gibbs, The Human Genome, FDA and Product Liability
Mr. Gibbs describes the risks to innovators associated with FDA regulations. He
also points out how developers and marketers of products based on human genome
research face such risks both before and after marketing.
. . . . . . . . . . . . . . . . . . . . . . . -267
Susan J. Timian & D. Michael Connolly, The Regulation and Devel-
opment of Bioremediation
The authors describe how federal statutes regulating hazardous wastes create both
incentives and disincentives for exploiting the large potential of bioremediation.
Ultimately, they argue for regulation attending more to comparative risks and costs.
. . . . . . . . . . . . . . . . . . . . . . . .. . 279
Meeting Announcements
Florida Managed Care Conference
First Meeting of the Florida Managed Care Institute
September 9-11, 1996; Orlando FL
Contact Lorry Davis, FMCI Program Planner, 3807 NW 53d Terr,
Gainesville FL 32606. Phone (352) 372-9360; fax 373-8034.
Assessing the Risks of Adverse Endoctrine-Mediated Risks
International Society of Regulatory Toxicology & Pharmacology
January 13-14, 1997; Research Triangle Park NC
Contact C. Jellef Carr, Secretary ISRTP, 6546 Bellview, Columbia
MD 21046. Phone (410) 992-9083; fax 740-9181.
First Biannual International Meeting
Risk Assessment & Policy Association
March 6-7, 1997; Alexandria VA
Contact Carol Ruh, Asst. Secretary-Treasurer, RAPA - see inside
front cover, this issue.
Correction
Please note the italicized omission from a sentence, at 6 Risk 346:
Preferences involving value hierarchy, H, have property, P, involving
preferences (with or without uncertainty) if, and only if, aggregation
function fH using weights wi, ... , wn has convenient property Fp, e.g.,
linear, multilinear or multiplicative.
